Psych Central

Etomine (clotiapine)

DocJohn — Fri, 03 May 2013 06:32:46 -0500

by: DocJohn

Description: <p><strong>What is Etomine?</strong> <p> Etomine is an atypical antipsychotic medication used to treat anxiety, mania or schizophrenia. It is considered a short-acting drug and has general properties similar to those of phenothiazines. <p> <strong>What should I avoid while taking Etomine?</strong> <p> Your doctor will warn you to avoid alcohol, anticholinergics, antihypertensives, smoking, barbiturates, beta blockers, tricyclic and some SSRI antidepressants (fluoxetine, paroxetine or sertraline) while taking this medication. <p> <strong>What dose is usually prescribed?</strong> <p> Etomine is usually prescribed in 10-200 mg/day divided doses, up to 360 mg/day for severe psychosis. <p> <strong>What are the side effects?</strong> <p> An altered body temperature regulation; neuroleptic malignant syndrome; CNS effects (extrapyramidal effects); GI disturbances; nasal congestion; antimuscurinic symptoms; CV symptoms, ECG changes; endocrine effects; blood dyscrasias; photosensitisation, contact sensitisation, rashes; jaundice; corneal and lens opacities; purplish pigmentation of skin and eye. <p>

Mental Stability

silver2row — Wed, 28 Nov 2012 19:53:30 -0600

by: silver2row

Description: This is my first piece of literature I made with booksmart software from Blurb.com. It still needs to be edited more. I am working on recreating it once more, i.e. to fit the format of a traditional book.

Here and Now

silver2row — Wed, 28 Nov 2012 19:47:18 -0600

by: silver2row

Description: This is a psychedelic art book of photography that has been edited in a way that brings out boasting colors.

MGMT Time To Pretend

Cookie505 — Thu, 20 Sep 2012 23:33:52 -0500

by: Cookie505

Description: I love this group. My favorite song by them is Kids.

hgjhgjhgjjgh

slashman — Mon, 27 Aug 2012 07:03:12 -0500

by: slashman

Description: jghjjjjjjjjjjj

Nutrition

runswithscissors42 — Sat, 04 Aug 2012 14:32:44 -0500

by: runswithscissors42

Description: I am non-plussed by the absence of nutrition in these categories. Nutrition and certain natural supplements have helped me considerably. Can sonmeone help me figure out how to approach that here so other self-help advocates so inclined might benefit similarly?

Undoing Depression

PH03N1X — Sat, 14 Apr 2012 12:39:43 -0500

by: PH03N1X

Description: Undoing Depression, What Therapy Doesn't Teach You And Medication Can't Give You. A new book. The first book to focus on prevention of depression. Written in clear, compelling language to patients, therapists, family and friends. Offers hope, help and education. ISBN 0-425-16679-1

Set The World On Fire

mcr_bvb_botdf — Wed, 11 Apr 2012 19:12:01 -0500

by: mcr_bvb_botdf

Description: A favorite album by one of my favorite artists, Set The World On Fire is, in my opinion, one of the best rock records ever created.

Invega (paliperidone)

DocJohn — Wed, 13 Apr 2011 13:04:01 -0500

by: DocJohn

Description: <h2>Invega</h2> <p> Invega (paliperidone) extended release tablets, an atypical antipsychotic medication, was approved in the U.S. in December 2006. <p> It is approved for the treatment of schizophrenia in adults and adolescents (12-17 years of age) in the U.S. The efficacy of Invega in schizophrenia was established in three six-week clinical trials in adults and in one six-week trial in adolescents (12-17 years of age), as well as in one maintenance trial in adults. <p> Invega is the only medication approved to treat schizoaffective disorder in adults. The efficacy of Invega in schizoaffective disorder was established in two six-week trials in adults. <p> <strong>Adverse Reactions</strong> <p> Commonly Observed Adverse Reactions: The most commonly observed adverse reactions in clinical trials occurring at an incidence of greater than or equal to 5% and at least 2 times placebo in the treatment of schizophrenia were: <p> <strong>Adults</strong> � extrapyramidal symptoms, tachycardia, and akathisia; <strong>Adolescents</strong> (12-17 years of age) were: somnolence, akathisia, tremor, dystonia, cogwheel rigidity, anxiety, weight increased and tachycardia. <p> The most commonly observed adverse reactions in clinical trials occurring at an incidence of greater than or equal to 5% and at least 2 times placebo in the treatment of schizoaffective disorder were: <strong>Adults</strong> - extrapyramidal symptoms, somnolence, dyspepsia, constipation, weight increased, and nasopharyngitis. <p> WARNING: Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of 17 placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in the drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. Invega is not approved for the treatment of patients with dementia-related psychosis. <p> Contraindications: Paliperidone is contraindicated in patients with a known hypersensitivity to either paliperidone, risperidone, or to any of the components in the formulation.

Viibryd (vilazodone hydrochloride)

DocJohn — Mon, 28 Feb 2011 19:28:59 -0600

by: DocJohn

Description: <h3>Viibryd (vilazodone hydrochloride)</h3> <p>Viibryd is indicated for the treatment of major depressive disorder (MDD) -- also known as clinical depression. The efficacy of Viibryd was established in two 8-week, placebo-controlled trials in adult patients with MDD.</p> <p><strong>Before Taking This Medication</strong></p> <p>Do not use Viibryd at the same time with an Monoamine Oxidase Inhibitors (MAOI) or within 14 days of stopping or starting an MAOI. </p><p> The most frequent adverse reactions reported by patients taking Viibryd in clinical trials included diarrhea, nausea, vomiting, and insomnia. </p><p> Viibryd and all other antidepressant drugs have a boxed warning and a patient medication guide describing the increased risk of suicidal thinking and behavior in children, adolescents, and young adults ages 18 to 24 during initial treatment. </p><p> The warning also says data did not show this increased risk in adults older than 24 and that patients ages 65 and older who take antidepressants have a decreased risk of suicidal thinking and behavior. The warning says depression and other serious psychiatric disorders themselves are the most important causes of suicide and that close monitoring of patients starting these medications is necessary. </p><p><strong>Warnings and Precautions</strong> </p><ul><li>Clinical Worsening/Suicide Risk: Monitor patients for clinical worsening and suicidal thinking or behavior. <li>Serotonin Syndrome or Neuroleptic Malignant (NMS)-like Syndrome: Can occur with treatment. Discontinue and initiate supportive treatment. <li>Seizures: Can occur with treatment. Use with caution in patients with a seizure disorder. <li>Abnormal Bleeding: Treatment can increase the risk of bleeding. Use with caution in association with nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, or other drugs that affect coagulation. <li>Activation of Mania/Hypomania: Can occur with treatment. Screen patients for bipolar disorder. <li>Discontinuation of Treatment with VIIBRYD: A gradual reduction in dose is recommended rather than an abrupt cessation. <li>Hyponatremia: Can occur in association with the syndrome of inappropriate antidiuretic hormone secretion (SIADH). </ul> <p><strong>Dosage</strong></p> <p>The recommended dose for Viibryd is 40 mg once daily. Viibryd should be titrated to the 40 mg dose, starting with an initial dose of 10 mg once daily for 7 days, followed by 20 mg once daily for an additional 7 days, and then increased to 40 mg once daily. </p><p> Viibryd should be taken with food. Administration without food can result in inadequate drug concentrations and may diminish effectiveness. </p><p> When discontinuing treatment, reduce the dose gradually. </p><p> Viibryd is manufactured by PGxHealth, New Haven, Conn.

Loxitane (Loxapine)

DocJohn — Thu, 10 Feb 2011 08:09:00 -0600

by: DocJohn

Description: <h1>Loxitane (Loxapine)</h1> <p> Loxitane is an antipsychotic medication which is prescribed most frequently to treat schizophrenia. </p><p> Loxitane may also be used for other mental health conditions as well, as prescribed by your doctor. Loxitane should not be used in patients with dementia.</p> <p><strong>Before Taking This Medication</strong></p> <p>Talk to your doctor about the following issues before taking Loxitane.</p> <p>If you have any of these conditions, you may need a dose adjustment or special tests to safely use loxapine: epilepsy or other seizure disorder; a history of low white blood cell (WBC) counts; glaucoma; urination problems; heart disease; or a history of breast cancer. </p> <p>Before using Loxitane, tell your doctor if you regularly use other medicines that make you sleepy (such as cold or allergy medicine, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression, or anxiety). You should not take loxapine if you have drowsiness caused by other medications. Tell your doctor about all other medications you use, especially: <ul><li>atropine (Atreza, Sal-Tropine), belladonna (Donnatal, and others), benztropine (Cogentin), dimenhydrinate (Dramamine), methscopolamine (Pamine), or scopolamine (Transderm-Scop); <li>bronchodilators such as ipratropium (Atrovent) or tiotropium (Spiriva); <li>glycopyrrolate (Robinul); <li>mepenzolate (Cantil); <li>bladder or urinary medications such as darifenacin (Enablex), flavoxate (Urispas), oxybutynin (Ditropan, Oxytrol), tolterodine (Detrol), or solifenacin (Vesicare); or <li>irritable bowel medications such as dicyclomine (Bentyl), hyoscyamine (Anaspaz, Cystospaz, Levsin, and others), or propantheline (Pro-Banthine). </ul> <p><strong>Dosage</strong></p> <p>Initial Dose: 10 mg twice daily is recommended, although an initial dosage up to a total of 50 mg daily may be given. Dosage should then be increased fairly rapidly over the first seven to ten days until there is effective control of symptoms of schizophrenia. </p><p> Maintenance Dose: 60 mg to 100 mg daily. </p><p> Maximum dose: 250 mg/day. </p> <p><strong>Missing a Dose</strong></p> <p> If you miss a dose of this medication, take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take extra medicine to make up the missed dose.</p>

Deplin (L-Methylfolate)

DocJohn — Thu, 10 Feb 2011 07:54:05 -0600

by: DocJohn

Description: <h1>Deplin (L-Methylfolate)</h1> <p>Deplin� is a trimonoamine modulator containing 7.5 mg of L-methylfolate, the only active form of folate that can cross the blood brain barrier. </p><p> L-methylfolate crosses the blood brain barrier and aids in the synthesis of new neurotransmitters (brain chemicals) associated with mood. </p><p> Deplin� works through a natural process in the brain to regulate all three monoamine neurotransmitters associated with mood by providing the increased dietary requirements for folate. L-methylfolate is needed by depressed patients with suboptimal folate to regulate the synthesis of monoamines (serotonin, norepinephrine and dopamine) and known as a trimonoamine modulator (TMM). By managing trimonoamine neurotransmitter synthesis, L-methylfolate, when taken with antidepressants, improves benefits. </p> <p>Deplin has been approved by the FDA as an adjunct -- in addition to -- medication for the treatment of depression and schizophrenia. </p> <p><strong>Before Taking This Medication</strong></p> <p> Some medications may interact with Deplin. Tell your health care provider if you are taking any other medicines, especially any of the following: </p><ul><li>Cholestyramine, colchicine, colestipol, nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen), or sulfasalazine because they may decrease Deplin's effectiveness <li>Fluorouracil because the risk of its side effects may be increased by Deplin <li>Barbiturates (eg, phenobarbital), carbamazepine, hydantoins (eg, phenytoin), primidone, or valproic acid because they may decrease Deplin's effectiveness; their effectiveness may also be decreased by Deplin <li>Pyrimethamine because its effectiveness may be decreased by Deplin </ul> <p><strong>Side Effects</strong></p> <p> Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue). </p> <p><strong>Dosage</strong></p> <p>The usual adult dose is 7.5 to 15 mg daily with or without food or as directed under medical supervision.</p> <p><strong>Safety Information</strong></p> <p> Some brands of Deplin may contain tartrazine dye (FD&C Yellow No. 5). This may cause an allergic reaction in some patients. If you have ever had an allergic reaction to tartrazine, ask your pharmacist if your product has tartrazine in it. </p><p> Lab tests, including blood counts, may be performed while you use Deplin. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments. </p><p>Deplin should be used with extreme caution in children; safety and effectiveness in children have not been confirmed. </p><p>Pregnancy / breast-feeding: It is not known if Deplin can cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Deplin while you are pregnant. Deplin is found in breast milk. If you are or will be breast-feeding while you use Deplin, check with your doctor. Discuss any possible risks to your baby. </p>

Courage to Heal (and Courage to Heal Workbook)

Christina86 — Mon, 02 Aug 2010 16:57:41 -0500

by: Christina86

Description: Come to terms with your past while moving powerfully into the future The Courage to Heal is an inspiring, comprehensive guide that offers hope and a map of the healing journey to every woman who was sexually abused as a child�and to those who care about her. Although the effects of child sexual abuse are long-term and severe, healing is possible. Weaving together personal experience with professional knowledge, the authors provide clear explanations, practical suggestions, and support throughout the healing process. Readers will feel recognized and encouraged by hundreds of moving first-person stories drawn from interviews and the authors' extensive work with survivors, both nationally and internationally. This completely revised and updated 20th anniversary edition continues to provide the compassionate wisdom the book has been famous for, as well as many new features: * Contemporary research on trauma and the brain * An overview of powerful new healing tools such as imagery, meditation, and body-centered practices * Additional stories that reflect an even greater diversity of survivor experiences * The reassuring accounts of survivors who have been healing for more than twenty years * The most comprehensive, up-to-date resource guide in the field * Insights from the authors' decades of experience Cherished by survivors, and recommended by therapists and institutions everywhere, The Courage to Heal has often been called the bible of healing from child sexual abuse. This new edition will continue to serve as the healing beacon it has always been.

Girl, Interrupted

Indie'sOK — Sun, 20 Jun 2010 11:31:02 -0500

by: Indie'sOK

Description: This book, as well as the movie, absolutely changed my life. In 1967, at 18 years old, Susanna Kaysen was hospitalized for depression after attempting suicide. What follows is her 18 month stay in Boston's McLean Hospital, where she is diagnosed with borderline personality disorder and eventually learns a lesson about herself that helps her break free from the grasp of her illness. Five stars.

Eat, Pray, Love

Indie'sOK — Sun, 20 Jun 2010 09:58:47 -0500

by: Indie'sOK

Description: Wonderful memoir by a very funny and talented woman about her search for new meaning in life after a heartbreaking divorce and breakup. In Italy, Liz learns the art of pleasure. In India, she discovers the secret to letting go of past demons. And in Bali, Indonesia, love makes its way into her life again, this time for good.

Labyrinths

Ygrec23 — Sun, 20 Jun 2010 09:11:21 -0500

by: Ygrec23

Description: This is a book of wonderful fantasy stories by a world-reknowned, blind Argentine auther who was the director of the Argentine National Library. Thinking of the way that PC is arranged makes me think of his stories. All of his works are available in English, though he wrote in Spanish. He is tremendously popular all around the world. When you read him, you may have my reaction: there is no one else like him other than those setting out specifically to imitate his style.

Center Point Binaural Auditory Technology

Gus1234U — Sat, 19 Jun 2010 13:08:37 -0500

by: Gus1234U

Description: Center Point is a description of the effects of an auditory stimulation of the brain. It was first developed in the '80's for use with children with ADD and other "behavioral problems". Further studies showed that it accomplished therapeutic improvements by stimulating ganglial (nerve receptor) growth in the meningial tissue which seperates the two halves of the brain, bringing about a rebalancing and rebuilding of brain function, which had the effects of stablizing mood disorders, which is to say sometimes curing depression, bipolar disorders, memory impairments and other various symptoms of brain dysfunction. The product is sold on CD's or Tapes which must be used with Stereo Headsets, so that the alternating subliminal sounds may stimulate the two sides of the brain to resolve this inequitible input, and thereby stimulate nerve receptor activation and even regrowth. This is a permanent improvement and does not diminish with time.

Twilight OST

black_crow — Sun, 13 Jun 2010 15:10:36 -0500

by: black_crow

Description: I dont only love this because its Twilight related but it genuinly has great music on it. You will love the music. I can just sit there and let it replay over and over again.

Pristiq

DocJohn — Sun, 25 Apr 2010 14:16:53 -0500

by: DocJohn

Description: Pristiq is an antidepressant in a group of drugs called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by restoring the balance of certain natural substances in the brain (serotonin and norepinephrine), which helps to improve certain mood problems. <br /><br /> Pristiq is used to treat major depressive disorder. <br /><br /> Pristiq may also be used for other purposes not listed in this medication guide. <br /><br /> <h4>Important information about Pristiq</h4> <br /><br /> Do not take Pristiq if you are allergic to desvenlafaxine or venlafaxine (Effexor), or if you are also using a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate). You must wait at least 14 days after stopping an MAOI before you can take Pristiq. After you stop taking Pristiq, you must wait at least 7 days before you start taking an MAOI. <br /><br /> You should not take Pristiq together with venlafaxine (Effexor). <br /><br /> You may have thoughts about suicide when you first start taking an antidepressant, especially if you are younger than 24 years old. Your doctor will need to check you at regular visits for at least the first 12 weeks of treatment. Call your doctor at once if you have any new or worsening symptoms such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself. <br /><br /> Avoid drinking alcohol, which can increase some of the side effects of Pristiq. It may take several weeks or more for your symptoms to improve. For best results, keep using the medication as directed. Do not stop using Pristiq without first talking to your doctor. You may have unpleasant side effects if you stop taking this medication suddenly. <br /><br /> <h4>Before taking Pristiq</h4> <br /><br /> Do not take Pristiq if you are allergic to desvenlafaxine or venlafaxine (Effexor), or if you are also using a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate). You must wait at least 14 days after stopping an MAOI before you can take Pristiq. After you stop taking Pristiq, you must wait at least 7 days before you start taking an MAOI. <br /><br /> You should not take Pristiq together with venlafaxine (Effexor). <br /><br /> If you have any of these other conditions, you may need a dose adjustment or special tests to safely take Pristiq: <br /><br /> <ul><li>bipolar disorder (manic depression); <li>liver disease; <li>kidney disease; <li>heart disease or high blood pressure; <li>a history of stroke; <li>glaucoma; <li>seizures or epilepsy; <li>a bleeding or blood clotting disorder; or <li>high cholesterol. </ul><br /><br /> You may have thoughts about suicide when you first start taking an antidepressant such as Pristiq, especially if you are younger than 24 years old. Tell your doctor if you have worsening symptoms of depression or suicidal thoughts during the first several weeks of treatment, or whenever your dose is changed. <br /><br /> Your family or other caregivers should also be alert to changes in your mood or symptoms. Your doctor will need to check you at regular visits for at least the first 12 weeks of treatment. FDA pregnancy category C. Pristiq may be harmful to an unborn baby, and may cause problems in a newborn baby if the mother takes the medication late in pregnancy (during the third trimester). Tell your doctor if you are pregnant or plan to become pregnant during treatment. Pristiq can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not give this medication to anyone under 18 years old without the advice of a doctor. <br /><br />

Depakote ER

sneschalmers — Sat, 10 Oct 2009 10:32:43 -0500

by: sneschalmers

Description: Anticonvulsant used as a mood stabilizer for bipolar disorder

Broken Mirror

Rhapsody — Wed, 23 Sep 2009 11:07:46 -0500

by: Rhapsody

Description: Understanding and Treating Body Dysmorphic Disorder - BDD.

The Wildest Colts Make the Best Horses

jennie — Thu, 09 Apr 2009 12:13:11 -0500

by: jennie

Description: <a href="http://www.wildestcolts.com/adhd/book.shtml" target="_blank">http://www.wildestcolts.com/adhd/book.shtml</a> Begin your journey of awareness regarding the oppressive "treatment" of our spirited children labeled with a mental disorder. Author: John Breeding Ph.D. Published: 1996

CeCe Winans

jeremiahgirl — Tue, 16 Dec 2008 17:24:38 -0600

by: jeremiahgirl

Description: songs

Mama's Kitchen

jeremiahgirl — Tue, 16 Dec 2008 17:18:10 -0600

by: jeremiahgirl

Description: Songs to build one's spirit

The Silver Boat

Orange_Blossom — Sat, 25 Oct 2008 14:32:21 -0500

by: Orange_Blossom

Description: The Silver Boat describes the journey that all of us must take in order to leave our pain behind and reach the healing place of "the warm and sunny land". This therapeutic metaphor, originally published in 1990, has both delighted and comforted thousands of people struggling with fears or the aftermath of abuse and trauma. For more info go to: http://www.sidran.org/store/index.cfm?fuseaction=product.display&Product_ID=31

Etherium Gold

sma1234 — Thu, 07 Aug 2008 06:00:12 -0500

by: sma1234

Description: Helps promotes mental clarity, improve focus and concentration. It has been clinically studied and shown to balance the two hemispheres of the brain and increase alpha brain wave production. It is generally accepted in neuroscience that this condition improves learning ability, increases creativity and reduces stress and restlessness

The Scarred Soul: Understanding & Ending Self-Inflicted Violence

Christina86 — Sun, 22 Jun 2008 23:21:18 -0500

by: Christina86

Description: Written by Tracy Alderman, Ph.D. (Written review/synopsis found online) Clinical psychologist Tracy Alderman takes a caring and compassionate look at why between one and two million people in the U.S. engage in acts of self-inflicted violence. She helps readers see that for some, SIV can be a means of breaking out of psychological numbness, while for others, physical pain is a way of focusing and controlling overwhelmingly chaotic feelings. The Scarred Soul is a step-by-step guide that helps victims of self-inflicted violence closely examine this behavior and take steps to reduce or eliminate it. This is the first book on the subject written for a general audience, the first to help educate those who have friends or relatives who are victims of self-inflicted violence, and the first to help victims understand they are not alone.

Super GLA/DHA 1000 mg

netty16 — Tue, 03 Jun 2008 20:03:06 -0500

by: netty16

Description: This is a fatty acid supplement. It is really useful for my bi-polar disorder symptoms. It contains Borage Seed Oil (GLA) and Marin Lipid Concentrate (DHA). I believe that essential fatty acids are recommended by many professionals as benefical for Mental Disorders.

Super GLA/DHA 1000 mg

netty16 — Tue, 03 Jun 2008 20:02:00 -0500

Man's Search for Meaning - Viktor Frankl

ten_new_songs — Sun, 01 Jun 2008 20:25:20 -0500

by: ten_new_songs

Description: very uplifting book, one that celebrates humanity's ability to rise above sadness and hardship.

Every red heart shines toward the red sun

ten_new_songs — Sun, 01 Jun 2008 20:22:23 -0500

by: ten_new_songs

Description: My favourite track is "like the howling glory"

Woven Hand

ten_new_songs — Sun, 01 Jun 2008 20:18:41 -0500

by: ten_new_songs

Description: gothic folk music

The Aware Baby

jennie — Thu, 27 Mar 2008 16:48:50 -0500

by: jennie

Description: THE AWARE BABY by Aletha Solter, Ph.D. This book will teach you how to: * Bond with your infant. * Respond to your baby's crying. * Enhance your baby's intelligence. * Help your baby sleep better. * Find alternatives to punishment. * Raise your child to be nonviolent. For more info <a href="http://www.awareparenting.com/books.htm" target="_blank">THE AWARE BABY</a>

Why Am I Afraid to Tell You Who I Am?: Insights Into Personal Growth

Christina86 — Sat, 08 Mar 2008 16:26:57 -0600

by: Christina86

Description: Only when we face our fears can we learn to like ourselves and trust that others will accept us. This extraordinary book has changed countless lives. This book is written from a (mildly) Christian perspective, and has a lot of helpful advice about how to change how we see ourselves, and how we relate to others.

Wellbutrin XL

AliceXCullen — Wed, 09 Jan 2008 21:19:21 -0600

by: AliceXCullen

Description: Depression medication

Norpramin (desipramine)

DocJohn — Fri, 04 Jan 2008 14:23:14 -0600

by: DocJohn

Description: Desipramine (known by brand names such as Norpramin or Pertofrane) displays an antidepressant property similar to that of other tricyclic antidepressants. It is the active "in vivo" metabolite of imipramine and as such, shares many of imipramine's pharmacologic effects. The anticholinergic actions of desipramine are responsible for many of the commonly observed side effects of the drug. Desipramine causes ECG changes such as prolongation of the P-R interval and a decreased magnitude with an increased width of the T wave. These ECG changes are seen most frequently in elderly patients as is postural hypotension. Desipramine is known to lower the convulsive threshold. Desipramine increases the percentage of Stage 4 sleep (deep sleep) and decreases the percentage of REM sleep. A partial recovery of REM sleep is seen after 3 to 5 weeks of drug administration. However, in spite of this recovery, a REM rebound occurs following rapid drug withdrawal, which is experienced as an increase in dreaming. The significance of these effects on the sleep cycle remains to be clarified. An increase in psychomotor activity is observed as an early manifestation of the effects of desipramine; however, a significant antidepressant effect should not be expected before the end of the second week. Desipramine is easily absorbed from the gastrointestinal tract following oral administration and is extensively bound to tissue and plasma proteins in the order of 90 to 95%. It is inactivated by hydroxylation and by further demethylation in the liver. Desipramine is excreted as a glucuronide largely in the urine (approximately 70%) and partly in the bile. Therapeutic actions of tricyclic antidepressants seem to be related to their plasma steady state which, given the same oral dosages, can vary considerably from one individual to another. The largest influence on steady state levels seems to be genetic; however, the influence of concomitant drug administration is also of some practical clinical significance (see Dosage). <h3>Indications</h3> Treatment of endogenous depressive illness, including the depressed phase of manic depressive illness, involutional melancholia and psychotic depression. It may also be indicated in the management of depression of a nonpsychotic degree such as in selected cases of depressive neurosis. Patients with transient mood disturbances or normal grief reaction are not expected to benefit from tricyclic antidepressants. <h3>Contraindications</h3> Desipramine should not be given in conjunction with, or within 2 weeks of, treatment with a MAO inhibitor; hyperpyretic crises, severe convulsions and death have occurred in patients receiving MAO inhibitors and tricyclic antidepressants. When desipramine is substituted for an MAO inhibitor, at least 2 weeks should elapse between the treatments; administration of desipramine should then be started cautiously and should be increased gradually. The drug is contraindicated in the acute recovery period following myocardial infarction or in cases of poorly controlled cardiac decompensation. It should not be used in those who have shown prior hypersensitivity to the drug. Cross-sensitivity between this and other dibenzazepines is a possibility. <h3>Warnings</h3> Extreme caution should be used when desipramine is given in the following situations: (1) In patients with cardiovascular disease, because of the possibility of conduction defects, arrhythmias, tachycardias, strokes and acute myocardial infarction. (2) In patients with a history of urinary retention or glaucoma, because of the anticholinergic properties of the drug. (3) In patients with thyroid disease or those taking thyroid medication, because of the possibility of cardiovascular toxicity, including arrhythmias. (4) In patients with a history of seizure disorder, because this drug has been shown to lower the seizure threshold. <strong>Occupational Hazards:</strong> Desipramine may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery; therefore, the patient should be cautioned accordingly. <strong>Pregnancy and Lactation:</strong> Safe use of desipramine during pregnancy and lactation has not been established; therefore, if it is to be administered to pregnant patients, nursing mothers, or women of childbearing potential, the possible benefits must be weighed against the possible hazards to mother and child. Animal reproductive studies have been inconclusive. <strong>Children:</strong> Not recommended for use in children since safety and effectiveness in the pediatric age group have not been established (see Adverse Effects, Cardiovascular). <h3>Precautions</h3> It is important that this drug be dispensed in the least possible quantities to depressed outpatients, since suicide has been accomplished with this class of drug. Ordinary prudence requires that children not have access to this drug, or to potent drugs of any kind; if possible, this drug should be dispensed in containers with child-resistant safety closures. Storage of this drug in the home must be supervised responsibly. If serious adverse effects occur, dosage should be reduced or treatment altered. Desipramine therapy in patients with manic-depressive illness may induce a hypomanic state after the depressive phase terminates. The drug may cause exacerbation of psychosis in schizophrenic patients. There is limited clinical experience in the concurrent administration of ECT and antidepressant drugs. Thus, if such treatment is essential, the possibility of increased risk relative to benefits should be considered. Both elevation and lowering of blood sugar levels have been reported. Leukocyte and differential counts should be performed in any patient who develops fever and sore throat during therapy; the drug should be discontinued if there is evidence of pathological neutrophil depression. <strong>Drug Interactions:</strong> Norpramin may potentiate the effect of a variety of drugs. Close supervision and careful adjustment of dosage are required when this drug is administered concomitantly with anticholinergic or sympathomimetic drugs. Patients should be warned that, while taking desipramine, their response to alcoholic beverages or other CNS depressants may be exaggerated. This drug should be discontinued as soon as possible prior to elective surgery because of possible cardiovascular effects. Hypertensive episodes have been observed during surgery in patients on desipramine. The contraindication regarding its concomitant use with MAO inhibitors should be noted, as well as the warning regarding patients taking thyroid medication. Desipramine, on the other hand, may decrease the action of other drugs; it is capable of blocking the antihypertensive effect of guanethidine and similarly acting compounds by blocking their uptake into adrenergic neurones. There have been greater than twofold increases of previously stable plasma levels of tricyclic antidepressants when fluoxetine has been administered in combination with these agents. <h3>Adverse Effects</h3> The more common adverse reactions involve anticholinergic effects such as dry mouth, disturbances of visual accommodation, constipation and mild urinary retention. Also commonly seen are light headedness, drowsiness, increased perspiration and mild tremors as well as insomnia. Adverse reactions of the cardiovascular system may be much more serious, however, these occur less frequently. Note: Included in the listing that follows are a few adverse reactions that have not been reported with desipramine. However, the pharmacological similarities among the tricyclic antidepressant drugs require that each of the reactions be considered when desipramine is administered. Cardiovascular: Hypotension, hypertension, tachycardia, palpitation, arrhythmias, heart block, myocardial infarction, stroke, premature ventricular contractions, ventricular tachycardia, ventricular fibrillation, sudden death. There has been a report of an acute collapse and sudden death in an 8-year old (18 kg) male, treated for 2 years for hyperactivity. There have been additional reports of sudden death in children. Psychiatric: Confusional states (especially in the elderly) with hallucinations, disorientation, delusions; anxiety, restlessness, agitation; insomnia and nightmares; hypomania; exacerbation of psychosis. Neurological: Numbness, tingling, paresthesias of extremities; incoordination, ataxia, tremors; peripheral neuropathy; extrapyramidal symptoms; seizures; alteration in EEG patterns; tinnitus. Anticholinergic: Dry mouth, and rarely associated sublingual adenitis; blurred vision, disturbance of accommodation, mydriasis; constipation, paralytic ileus; urinary retention, delayed micturition, dilatation of urinary tract. Allergic: Skin rash, petechiae, urticaria, itching, photosensitization (excessive exposure to sunlight should be avoided), edema (of face and tongue or general), drug fever, cross sensitivity with other tricyclic drugs. Hematologic: Bone marrow depressions including agranulocytosis, eosinophilia, purpura, thrombocytopenia. Gastrointestinal: Anorexia, nausea and vomiting, epigastric distress, peculiar taste, abdominal cramps, diarrhea, stomatitis, black tongue, hepatitis, jaundice (simulating obstructive), altered liver function, elevated liver function tests, increased pancreatic enzymes. Endocrine: Gynecomastia in the male, breast enlargement and galactorrhea in the female; increased or decreased libido, impotence, painful ejaculation, testicular swelling; elevation or depression of blood sugar levels; syndrome of inappropriate antidiuretic hormone secretion (SIADH). Other: Jaundice (simulating obstructive), altered liver function; weight gain or loss; perspiration, flushing, urinary frequency, nocturia; parotid swelling; drowsiness, dizziness, weakness and fatigue, headache; alopecia; elevated alkaline phosphatase. Withdrawal Symptoms: Though not indicative of addiction, abrupt cessation of treatment after prolonged therapy may produce nausea, headache, malaise and abdominal cramping. <h3>Overdose</h3> Symptoms: In patients presenting with signs of peripheral atropine effects, agitation and cardiac arrhythmias, the possibility of tricyclic antidepressant overdosage should be entertained. In view of the extensive tissue and protein binding of these drugs, blood and urine levels may not accurately reflect the extent of intoxication but may be helpful in identifying the presence of the drug. The following signs and symptoms of overdosage may occur; reflecting CNS intoxication, the patient may exhibit pressure of speech, agitation, hallucinations, hyperacusia, choreoathetoid movements and myoclonus which may be mistaken for seizures, increased tendon reflexes, Babinski reflex, grand mal seizures and hyperactive coma progressing to flaccid coma; the cardiovascular complications are the most life threatening and may involve arrhythmias including tachycardia, nodal tachycardia, atrioventricular block, intraventricular conduction delays and asystole as well as myocardial damage, congestive heart failure and shock; in general, other signs of intoxication would also resemble those of atropine poisoning and would include flushed skin, dry mouth, dilated pupils, pyrexia, urinary retention with distended bladder and rarely, adynamic ileus. Treatment: General management measures as in other cases of coma and shock would be applicable including bladder catheterization, cardiac monitoring, etc. Early appropriate evacuation of the ingested material and/or the use of activated charcoal is indicated. Injectable physostigmine salicylate is presently considered the treatment of choice in the reversal of the more severe CNS and cardiovascular complications of poisoning from tricyclic antidepressants. However, in uncomplicated cases the use of this drug may not be indicated, or, may be used as a therapeutic trial only, in a reduced dosage of 1 mg injected slowly i.v. In adults, the usual dosage of physostigmine in severe cases of poisoning would be 1 to 2 mg injected i.v. over a period of about 2 minutes. The therapeutic response may be seen, often dramatically, within 5 minutes of the injection. Since physostigmine is a short-acting drug, repeat injections in more severe, responsive, cases may be needed at 30 to 60 minute intervals, provided there are no serious signs of cholinergic effects. According to one author the initial pediatric dose should be 0.5 mg administered slowly i.v. in cases of acute tricyclic antidepressant poisoning. If toxic signs persist and no serious cholinergic effects are produced, the drug can be re-administered at 5 minute intervals until a maximum dose of 2 mg is obtained. If physostigmine salicylate is used, atropine sulfate should be available to reverse excessive cholinergic effects such as bradycardia, marked salivation, emesis and bronchospasm. In the event of such a cholinergic crisis, atropine sulfate in a dosage equal to one-half of the physostigmine dosage may be given in order to control the muscarinic effects of the physostigmine. Other measures of the value in tricyclic antidepressant overdose may include: diazepam for the control of persistent seizures; and careful management of electrolyte and acid-base balance. The various dialysis techniques are relatively ineffective in reversing signs of overdosage because of the low free plasma levels and the firm tissue and protein binding of these drugs. Forced diuresis is of limited value. Digitalis, if possible, should be avoided due to its tendency to aggravate cardiac conduction problems. Prolonged observation of at least a week is strongly recommended since deaths attributed to arrhythmias have been reported many days following an apparent recovery from a tricyclic antidepressant overdose. <h3>Dosage</h3> Not recommended for use in children. Lower dosages are recommended for elderly and debilitated patients. Lower dosages are also recommended for outpatients compared to hospitalized patients, who are closely supervised. Dosage should be initiated at a low level and increased according to clinical response and any evidence of intolerance. Following remission, maintenance medication may be required for a period of time and should be at the lowest dose that will maintain remission. <strong>Adults:</strong> The usual adult dose is 100 to 200 mg/day. In more severely ill patients, dosage may be further increased gradually to 300 mg/day if necessary. Dosages above 300 mg/day are not recommended. Dosages should be initiated at a lower level and increased according to tolerance and clinical response. Treatment of patients requiring as much as 300 mg should generally be initiated in hospitals, where regular visits by the physician, skilled nursing care and frequent ECGs are available. The best available evidence of impending toxicity from very high doses of desipramine is prolongation of the QRS or QT intervals on the ECG. Prolongation of the PR interval is also significant, but less closely correlated with plasma levels. Clinical symptoms of intolerance, especially drowsiness, dizziness, and postural hypotension, should also alert the physician to the need for reduction in dosage. Plasam desipramine measurement would constitute the optimal guide to dosage monitoring. Initial therapy may be administered in divided doses or a single daily dose. Maintenance therapy may be given on a once-daily schedule for patient convenience and compliance. <strong>Geriatrics and Debilitated:</strong> Patient dose: The usual elderly and debilitated patient dose is 25 to 100 mg daily. Dosage should be initiated at a lower level and increased according to tolerance and clinical response to a usual maximum of 100 mg daily. In more severely ill patients, dosage may be further increased to 150 mg/day. Doses above 150 mg/day are not recommended in these patients. Initial therapy may be administered in divided doses or a single daily dose. Maintenance therapy may be given on a once-daily schedule for patient convenience and compliance.

Feeling Good: The New Mood Therapy

wbl526 — Fri, 07 Sep 2007 05:25:37 -0500

by: wbl526

Description: Dr. Burns describes how to combat feelings of depression so you can develop greater self-esteem. This best-selling book has sold over 4 million copies worldwide to date. In a recent national survey of mental health professionals, Feeling Good was rated #1--out of a list of 1000 books--as the most frequently recommended self-help book on depression in the United States.

The Bipolar Disorder Survival Guide: What You and Your Family Need to Know

wbl526 — Mon, 27 Aug 2007 19:05:32 -0500

by: wbl526

Description: From Library Journal Hard on the heels of Fuller Torrey and Michael B. Knable's excellent Surviving Manic Depression: A Manual on Bipolar Disorder for Patients, Families and Providers (LJ 1/02) comes another strong title. Both books cover the origins, symptoms, and treatments for bipolar disorder, with emphasis on current medications. The main difference between the two books is that the current title by Miklowitz (psychology, Univ. of Colorado, Boulder) is intended for patients. It spends a good deal of time on issues exclusive to the sufferer how to come to terms with the diagnosis, whom to confide in, and how to recognize one's own mood swings. More concise in its treatment of the issues just mentioned, Torrey and Knable's title is addressed to a more general audience, spends more time reviewing the scientific evidence concerning the origins of the disease, and has a much more useful resource list. On the whole, Surviving Manic Depression would be the first choice for most libraries, with Miklowitz's book recommended for patient education libraries and medium and large public libraries. Mary Ann Hughes, Neill P.L., Pullman, WA Copyright 2002 Reed Business Information, Inc. Demitri F. Papolos, MD, and Janice Papolos, authors of Overcoming Depression and The Bipolar Child "This book should be required reading for people with the disorder, their family members, and the therapists who treat them." --This text refers to the Hardcover edition.

Anger Management

arinovick — Thu, 23 Aug 2007 20:24:57 -0500

by: arinovick

Description: Anger Management for the Twenty-first Century is a client workbook which teaches skills in anger and stress management. This model teaches the 8 tools of anger control and is used by certified anger management providers of Century Anger Management. It is also a great self-help book for individuals struggling with anger related issues. More information can be found at www.ajnovickgroup.com or www.centuryangermanagement.com

Daytrana (methylphenidate)

DocJohn — Tue, 21 Aug 2007 16:03:48 -0500

by: DocJohn

Description: <table cellpadding="0" border="0" cellspacing="4" width="100%"><tr><td width="80%"><div align="center"><h2>Daytrana<br />(methylphenidate)</h2></div><div id="content" class="article"><p> Daytrana is a central nervous system (CNS) stimulant prescription medicine. Daytrana is a skin patch that releases the medication contained in the adhesive (glue) through clean and intact skin areas into the bloodstream when applied to the skin on the hips. It is used for the treatment of <a href="http://psychcentral.com/disorders/adhd/">Attention Deficit Hyperactivity Disorder</a> (ADHD). Daytrana may help increase attention and decrease impulsiveness and hyperactivity in patients with ADHD. Daytrana should be used as a part of a total treatment program for ADHD that may include counseling or other therapies. <ul><li>Medical studies have shown that Daytrana can provide significant improvement of inattention and hyperactive/impulsive symptoms of ADHD. <li>Classroom studies of children with ADHD showed that children taking Daytrana not only tried more math problems, but also completed more math problems correctly than those taking placebo. <li>In clinical studies, side effects were generally mild to moderate. <li>Slower growth (weight gain and/or height) has been reported in children taking methylphenidate over long periods of time. Your doctor will monitor your child's growth/weight gain while taking Daytrana, and may re-revaluate his or her treatment if necessary. <li>Daytrana is applied to the hip area each morning. When worn as directed, the patch provides medicine continuously throughout your child's waking day as long as he or she has it on. <li>It�s recommended that the patch be worn for 9 hours; its effects continue for 3 hours after it�s removed. The Daytrana patch may be taken off sooner to help manage the potential for late-day side effects. <li>Daytrana is clear, flexible and discreet. Daytrana may be a good fit for children who don't like taking pills every morning. <li>Daytrana is designed to provide daylong adhesion during activities such as swimming, exercising and bathing. <li>Clinical studies showed that most children were not bothered wearing the patch. Accompanying the benefits of this medication are the associated risks such as side effects and skin irritation; therefore, it is important that you read the Important Safety Information before beginning treatment. </ul> <h3>What is the most important information I should know about Daytrana?</h3> Daytrana is a stimulant medicine. The following have been reported with use of Daytrana (methylphenidate transdermal system) or other stimulant medicines: <strong>1. Heart-related problems:</strong> <ul><li>sudden death in patients who have heart problems or heart defects <li>stroke and heart attack in adults <li>increased blood pressure and heart rate </ul> Tell your doctor if you or your child has any heart problems, heart defects, high blood pressure, or a family history of these problems. Your doctor should check you or your child carefully for heart problems before starting Daytrana. Your doctor should check your or your child�s blood pressure and heart rate regularly during treatment with Daytrana. Remove patch immediately and call your doctor right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting while using Daytrana. <strong>2. Mental (Psychiatric) problems:</strong> <strong>All Patients:</strong> <ul><li>new or worse behavior and thought problems <li>new or worse bipolar illness <li>new or worse aggressive behavior or hostility </ul> <strong>Children and Teenagers</strong> <ul><li>new psychotic symptoms (such as hearing voices, believing things that are not true, are suspicious) or new manic symptoms </ul> Tell your doctor about any mental problems you or your child has, or about a family history of suicide, bipolar illness, or depression. Call your doctor right away if you or your child has any new or worsening mental symptoms or problems while using Daytrana, especially seeing or hearing things that t are not real, believing things that are not real, or are suspicious. <h3>What are possible side effects of Daytrana?</h3> Skin reactions including skin irritation and allergic skin rash can happen with Daytrana. Skin redness or itching at the application site is common. You can keep using Daytrana if this happens. Stop using Daytrana and see your doctor right away if swelling, bumps, or blisters happen at or around the application site. You may have a skin allergy to Daytrana. People that have skin allergies with Daytrana may develop an allergy to all medicines that contain methylphenidate, even those taken by mouth. See �What is the most important information I should know about Daytrana� for information on reported heart and mental problems. <strong>Other serious side effects include:</strong> <ul><li>slowing of growth (height and weight) in children <li>seizures, mainly in patients with a history of seizures <li>eyesight changes or blurred vision </ul> <strong>Common side effects include:</strong> <ul> <li>nausea <li>trouble sleeping <li>decreased appetite <li>tics <li>vomiting <li>mood swings <li>decreased weight </ul> Talk to your doctor if you or your child has side effects that are bothersome or do not go away. This is not a complete list of possible side effects. Ask your doctor or pharmacist for more information. <h3>How should I store Daytrana?</h3> Store Daytrana in a safe place at room temperature, 59 to 86� F (15 to 30� C). Keep Daytrana patches in their unopened pouches until ready to use. Once a tray of patches has been opened, use or discard the patches within 2 months. Keep Daytrana and all medicines out of the reach of children. <h3>General information about Daytrana</h3> Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use Daytrana for a condition for which it was not prescribed. Do not give Daytrana to other people, even if they have the same condition. It may harm them and it is against the law. This Medication Guide summarizes the most important information about Daytrana. If you would like more information, talk with your doctor. You can ask your doctor or pharmacist for information about Daytrana that was written for healthcare professionals. </div></td></tr></table>

5-HTP

Mother_Goose — Fri, 03 Aug 2007 14:21:12 -0500

by: Mother_Goose

Description: 5-Hydroxytryptophan (5-HTP) is an amino acid that is the intermediate step between tryptophan and the important brain chemical serotonin. There is a massive amount of evidence that suggests that low serotonin levels are a common consequence of modern living. The lifestyle and dietary practices of many people living in this stress-filled era results in lowered levels of serotonin within the brain. As a result, many people are overweight, crave sugar and other carbohydrates, experience bouts of depression, get frequent headaches, and have vague muscle aches and pain. All of these maladies are correctable by raising brain serotonin levels. The primary therapeutic applications for 5-HTP are low serotonin states as listed in Table 1. Table 1. Conditions associated with low serotonin levels helped by 5-HTP Depression Obesity Carbohydrate craving Bulimia Insomnia Narcolepsy Sleep apnea Migraine headaches Tension headaches Chronic daily headaches Premenstrual syndrome Fibromyalgia Although 5-HTP may be relatively new to the United States health food industry, it has been available through pharmacies for several years and has been intensely researched for the past three decades. It has been available in several European countries as a medicine since the 1970s.

Kava Kava

Mother_Goose — Fri, 03 Aug 2007 13:17:26 -0500

by: Mother_Goose

Description: Recent clinical studies have shown that the herb kava is a safe nonaddictive anti-anxiety medicine, and as effective as prescription anxiety agents containing benzodiazepines such as valium. While benzodiazepines tend to promote lethargy and mental impairment, kava has been shown to improve concentration, memory, and reaction time for people suffering from anxiety. Kava has been clinically demonstrated as a means of achieving a state of relaxation without the adverse side effects. Kava is mildly narcotic and produces mild euphoric changes characterized by elevated mood, fluent and lively speech and increased sense of sound. Higher doses can lead to muscle weakness, visual impairment, dizziness and drying of the skin. Long term use of the herb can contribute to hypertension, reduced protein levels, blood cell abnormalities, or liver damage. Alcohol consumption increases the toxicity of the pharmacological constituents. It is not recommended for those who intend on driving or where quick reaction time is required. Kava is the most relaxing botanical herb with exception of the opium poppy. Pharmacological studies show kava kava's active ingredients, kavalactones, produce physical and mental relaxation and a feeling of well being. It has also been used in the treatment of ailments of the genitourinary tract including vaginitis, gonorrhea and menstrual cramps. Kava is a diuretic and an anti-inflammatory, thus useful for gout, rheumatism, bronchial congestion, cystitis and prostatis. It is an effective local anesthetic and pain reliever when applied externally as a liniment. The relaxed state and sharpening of senses also contribute to aphrodisiac effect.

Stresszero techniques (tapping)

Landau — Thu, 12 Jul 2007 16:51:14 -0500

by: Landau

Description: Originally designed to augment the world of psychotherapy we found that Stresszero tapping also relieves all kinds of physical symptoms from migraine headaches to cancer. Stresszero methods often work when nothing else will. You have to experience it to believe it! ))) Free instruction to do-it-yourself at the Stresszero site.

The Arcade Fire - Neon Bible

radioheadfan22 — Wed, 11 Jul 2007 01:40:52 -0500

by: radioheadfan22

Description: The highly anticipated second album from the Arcade Fire, which debuted in March 2007 at the No. 2 spot on the US and UK charts. Deeper, darker, and more majestic than its predecessor. Highlight tracks include "Intervention" and "My Body Is A Cage", which both utilize a church pipe organ (a new addition to the band's already extensive instrumental arsenal), the frantic "(Antichrist Television Blues)", and chilling opener "Black Mirror".

The Arcade Fire - Funeral

radioheadfan22 — Wed, 11 Jul 2007 00:18:34 -0500

by: radioheadfan22

Description: The 2004 critically acclaimed debut from Montreal's Arcade Fire. "Funeral" layers crunchy guitars, intricate string arrangements, and desperate crescendos for an album that is by turns melancholic, playful, and angry, but thoroughly beautiful. Highlight tracks include the gorgeous, howling "Neighborhood #1 (Tunnels)", the driving intensity of "Neighborhood #3 (Power Out)" and its concert set-mate "Rebellion (Lies)", and the powerful anthem "Wake Up".

The Suicidal Mind

DePressMe — Thu, 05 Jul 2007 10:05:44 -0500

by: DePressMe

Description: The Suicidal Mind by Edwin Schneidman. Well written book for the lay person or professional. Dr. Schneidman compassionately and insightfully explores 10 common psychological themes of suicide such as loneliness and isolation. He examines 3 cases of individuals who attempted suicide, but lived. He also proposes 24 psychotherapeutic tools for recovery for the suicidal person. You might find this book to be a useful tool in therapy.

Emsam - Patch

sharon1510 — Tue, 03 Jul 2007 16:18:23 -0500

by: sharon1510

Description: This is an MAOI which is like Nardil or Parnate. It is a patch that if used at a low dosage, you don't have as many restrictions. I wanted to know if anyone has used this and if it helped.

The Self-Esteem Workbook

canders7 — Tue, 12 Jun 2007 21:50:03 -0500

by: canders7

Description: (New Harbinger Pubns) Presents a course in self-esteem based on new research and sound principles. Includes checklists, fill-ins, and exercises to show readers how thoughts, emotions, physical health, and behavior impact their self-esteem.

It's Not My Fault - The No-Excuse Plan to Put You in Charge of Your Life

canders7 — Tue, 12 Jun 2007 21:43:06 -0500

by: canders7

Description: "It's not my fault" The most common excuse. The most dangerous trap. (taken from back cover) It seems like just a common, no-harm-done excuse. It can even seem like the truth. But according to Drs. Henry Cloud and John Townsend, it's really a dangerous, self-destructive trap that keeps you from the life you want to live.

Vyvanse (lisdexamfetamine)

DocJohn — Wed, 06 Jun 2007 07:52:12 -0500

by: DocJohn

Description: <table border="0" cellpadding="0" cellspacing="0" width="600"><tr> <td width="74%" valign="top" align="left"> <font size="2" face="Arial, Helvetica, sans-serif" color="#000000"> Vyvanse is a central nervous system stimulant used to treat <a href="/disorders/adhd/">attention deficit disorder</a> (ADHD). It affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control. Vyvanse may also be used for purposes other than those listed in this medication guide. <h3>What are the common side effects of Vyvanse?</h3> Some possible common side-effects of Vyvanse include:<ul><li>nausea, vomiting, stomach pain, loss of appetite, weight loss; <li>blurred vision; <li>skin rash; <li>feeling irritable; <li>sleep problems (insomnia); or <li>dry mouth or an unpleasant taste in your mouth. </ul>Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. <h3>What are the uncommon side effects of Vyvanse?</h3> Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using Vyvanse and call your doctor at once if you have any of these serious side effects:<ul><li>fast, pounding, or uneven heartbeats; <li>decreased blood pressure (feeling light-headed, fainting); <li>increased blood pressure (severe headache, blurred vision, trouble concentrating, chest pain, numbness, seizure); or <li>tremor, restlessness, hallucinations, unusual behavior, or motor tics (muscle twitches). </ul><h3>What should I know about Vyvanse?</h3> Do not use Vyvanse if you have used an MAO inhibitor such as isocarboxazid (Marplan), tranylcypromine (Parnate), phenelzine (Nardil), rasagiline (Azilect), or selegiline (Eldepryl, Emsam) within the past 14 days. Serious, life-threatening side effects can occur if you take Vyvanse before the MAO inhibitor has cleared from your body. Do not use Vyvanse if you are allergic to lisdexamfetamine, or if you have hardened arteries (arteriosclerosis), heart disease, moderate to severe high blood pressure (hypertension), overactive thyroid, glaucoma, severe anxiety or agitation, or a history of drug or alcohol addiction. Some stimulants have caused sudden death in children and adolescents with serious heart problems or congenital heart defects. Before taking Vyvanse, tell your doctor if you have any type of heart problems. Vyvanse may be habit-forming and should be used only by the person it was prescribed for. Vyvanse should never be given to another person, especially someone who has a history of drug abuse or addiction. Keep the medication in a secure place where others cannot get to it. Using Vyvanse improperly can cause death or serious side effects on the heart. Do not use this medication if you are allergic to Vyvanse or if you have:<ul><li>heart disease or moderate to severe high blood pressure (hypertension); <li>arteriosclerosis (hardening of the arteries); <li>overactive thyroid; <li>glaucoma; <li>severe anxiety, tension, or agitation; or <li>if you have a history of drug or alcohol addiction. </ul>Some stimulants have caused sudden death in children and adolescents with serious heart problems or congenital heart defects. Before using Vyvanse, tell your doctor if you are allergic to any drugs, or if you have:<ul><li>a congenital heart defect; <li>high blood pressure; <li>heart failure, heart rhythm disorder, or recent heart attack; <li>a personal or family history of mental illness, psychotic disorder, bipolar illness, depression, or suicide attempt; <li>epilepsy or other seizure disorder; or <li>tics (muscle twitches) or Tourette's syndrome. </ul>If you have any of these conditions, you may not be able to use Vyvanse, or you may need a dosage adjustment or special tests during treatment. <strong>FDA pregnancy category C.</strong> This medication may be harmful to an unborn baby. It could also cause premature birth, low birth weight, or withdrawal symptoms in a newborn if the mother takes this medication during pregnancy. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Vyvanse can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. <strong>Long-term use of Vyvanse can slow a child's growth.</strong> Tell your doctor if the child using Vyvanse is not growing or gaining weight properly. Do not give Vyvanse to a child younger than 6 years old without the advice of a doctor. Vyvanse may be habit-forming and should be used only by the person it was prescribed for. Vyvanse should never be given to another person, especially someone who has a history of drug abuse or addiction. Keep the medication in a secure place where others cannot get to it. Using this medication improperly can cause death or serious side effects on the heart. <h3>How should I take Vyvanse?</h3> Take Vyvanse exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label. Your doctor may occasionally change your dose to make sure you get the best results from Vyvanse. You may also be asked to not use the medication for a day or two and watch for any differences in behavior off the medication. Take this medication with a full glass of water. It is best to take this medication in the morning. Do not take this medication in the afternoon or evening because it may cause sleep problems (insomnia). You may take this medication with or without food. The capsule should be swallowed whole. You may also open the Vyvanse capsule and sprinkle the medicine into a glass of water. After the medicine has dissolved, drink this mixture right away. Do not save the mixture for later use. Discard the empty capsule. To be sure this medication is helping your condition, your doctor will need to see you on a regular basis. Do not miss any scheduled visits to your doctor. This medication can cause you to have unusual results with certain medical tests. Tell any doctor who treats you that you are using Vyvanse. Store Vyvanse at room temperature away from moisture, heat, and light. Keep track of how many capsules have been used from each new bottle of this medicine. Vyvanse is a drug of abuse and you should be aware if any person in the household is using this medicine improperly or without a prescription. <h3>What happens if I miss a dose?</h3> Take the missed dose as soon as you remember. If it is almost time for your next dose, or if it is already evening, skip the missed dose and take the medicine the next morning. Taking this medicine late in the day can cause sleep problems. Do not take extra medicine to make up the missed dose. <h3>What happens if I overdose?</h3> Seek emergency medical attention if you think you have used too much of this medicine. An overdose of Vyvanse can be fatal. Symptoms of a Vyvanse overdose include restlessness, tremor, muscle twitches, rapid breathing, confusion, hallucinations, panic, aggressiveness, unexplained muscle pain or tenderness, muscle weakness, fever or flu symptoms, and dark colored urine. These symptoms may be followed by depression and tiredness. Other overdose symptoms include nausea, vomiting, diarrhea, stomach pain, uneven heartbeats, feeling light-headed, fainting, seizure (convulsions), or coma. <h3>What should I avoid while taking Vyvanse?</h3> Vyvanse can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking fruit juices or taking vitamin C at the same time you take Vyvanse. These can make your body absorb less of the medicine. <h3>What other drugs will affect Vyvanse?</h3> Before taking Vyvanse, tell your doctor if you are using any of the following drugs:<ul><li>ammonium chloride, ascorbic acid (vitamin C), K-Phos; <li>blood pressure medications; <li>a diuretic (water pill); <li>cold or allergy medicines (antihistamines); <li>chlorpromazine (Thorazine); <li>ethosuximide (Zarontin); <li>lithium (Eskalith, Lithobid); <li>methenamine (Hiprex, Mandelamine, Urex); <li>phenytoin (Dilantin), phenobarbital (Luminal, Solfoton); <li>pain medication such as meperidine (Demerol) or propoxyphene (Darvon, Darvocet); or <li>antidepressants such as amitriptyline (Elavil), amoxapine (Ascendin), clomipramine (Anafranil), desipramine (Norpramin), imipramine (Tofranil), or nortriptyline (Pamelor). </ul>If you are using any of these drugs, you may not be able to use Vyvanse, or you may need dosage adjustments or special tests during treatment. There may be other drugs not listed that can affect Vyvanse. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor. <h3>Where can I get more information?</h3> Your pharmacist has information about Vyvanse written for health professionals that you may read. <h3>What does my medication look like?</h3> Lisdexamfetamine is available with a prescription under the brand name Vyvanse. Other formulations may also be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.<ul><li>Vyvanse 30 mg - white and orange capsule <li>Vyvanse 50 mg - white and blue capsule <li>Vyvanse 70 mg - blue and orange capsule </ul> </font></td></tr></table>